AgeTech Clinic

Hearing Assistive Technology

The FDA's approval of Over-The-Counter (OTC) hearing aids has flooded the market with Direct-to-Consumer (DTC) amplifiers. While this democratizes access, it places the burden of audiological tuning onto the consumer. We evaluate these devices on their self-fitting algorithms and acoustic isolation.

Amplification vs. Isolation

A $50 amplifier makes everything louder, including background noise (the "restaurant problem"). A true assistive device isolates human speech frequencies (typically 500Hz to 4000Hz) while suppressing ambient noise. We strictly penalize devices that lack directional microphones or DSP (Digital Signal Processing).

The Data

71% Return rate of cheap ($<100) PSAPs (Personal Sound Amplification Products) due to background noise frustration.

Tool: OTC Viability Check

Determine if an Over-The-Counter device is suitable, or if a prescription audiologist visit is required.

SUITABLE FOR OTC

This device configuration matches the hearing profile.

Frequently Asked Questions

Is this assessment vendor-neutral?

Yes. AgeTech Clinic accepts zero funding or hardware from vendors. All metrics are independently derived from published clinical data.

How often is this data updated?

We review the clinical landscape quarterly. If a new firmware update significantly alters device performance, we update our matrix immediately.

Deep Dive: Related Clinical Assessments

Explore our full matrix of technology evaluations. Each area focuses on distinct physical, cognitive, and architectural requirements for aging-in-place.